Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

SHSSX vs. SCHLX: which is better?

Bottom line

SHSSX vs SCHLX: the short answer

SHSSX (Blackrock Health Sciences Opportunities Portfolio) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 74% by weight.

But SHSSX is far broader, holding 155 positions to 65 for SCHLX, so beyond the top names it adds exposure SCHLX doesn't have.

SHSSX is cheaper at 0.86% vs 1.06% — a difference of $20 a year per $10,000 invested.

Updated Nov 19, 2026

SHSSX vs SCHLX side by side

SHSSXSCHLX
TypeMutual fundMutual fund
Fund familyBlackRockDWS (Xtrackers)
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.86%1.06%
Annual cost per $10k$86$106
10-yr cost on $10k (prospectus)$1,061$1,294
Max front load0%0%
12b-1 fee0%0%
1-yr return+16.3%—
5-yr return (annualized)+5.9%—
10-yr return (annualized)+9.8%—
Best quarter——
Worst quarter——
Net assets (fund)$5.9B$231.8M
Number of holdings15565
Portfolio turnover49%2%
Returns as ofDec 31, 2025—

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

17 of SHSSX's top 25 holdings also appear in SCHLX's top 25.

Shared top holdings
HoldingSHSSXSCHLX
Eli Lilly & Company12.29%13.85%
Johnson & Johnson8.77%6.19%
Unitedhealth Group Inc6.10%5.73%
Merck & Company Inc4.94%4.85%
Gilead Sciences Inc4.19%2.78%
Abbvie Inc3.94%4.90%
Amgen Inc3.37%2.88%
Thermo Fisher Scientific Inc3.02%3.46%
Vertex Pharmaceuticals Inc2.74%2.45%
Pfizer Inc2.61%1.17%
Danaher Corp2.00%2.13%
Abbott Laboratories1.97%2.39%
Intuitive Surgical Inc1.95%2.69%
Boston Scientific Corp1.59%2.10%
Astrazeneca Plc1.21%3.80%

Source: SEC Form N-PORT

SHSSX top 10

  1. Eli Lilly & Company — 12.29%
  2. Johnson & Johnson — 8.77%
  3. Unitedhealth Group Inc — 6.10%
  4. Merck & Company Inc — 4.94%
  5. Gilead Sciences Inc — 4.19%
  6. Abbvie Inc — 3.94%
  7. Amgen Inc — 3.37%
  8. Thermo Fisher Scientific Inc — 3.02%
  9. Vertex Pharmaceuticals Inc — 2.74%
  10. Pfizer Inc — 2.61%

SCHLX top 10

  1. Eli Lilly & Co — 13.85%
  2. Johnson & Johnson — 6.19%
  3. UnitedHealth Group Inc — 5.73%
  4. AbbVie Inc — 4.90%
  5. Merck & Co Inc — 4.85%
  6. AstraZeneca PLC — 3.80%
  7. Thermo Fisher Scientific Inc — 3.46%
  8. Novartis AG — 2.90%
  9. Amgen Inc — 2.88%
  10. Gilead Sciences Inc — 2.78%

FAQ

What is the difference between SHSSX and SCHLX?
SHSSX (Blackrock Health Sciences Opportunities Portfolio) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 74% by weight. But SHSSX is far broader, holding 155 positions to 65 for SCHLX, so beyond the top names it adds exposure SCHLX doesn't have.
Which is cheaper, SHSSX or SCHLX?
SHSSX has the lower expense ratio (0.86%).
Should I own both SHSSX and SCHLX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.